24.26
Precedente Chiudi:
$24.94
Aprire:
$24.63
Volume 24 ore:
1.36M
Relative Volume:
1.19
Capitalizzazione di mercato:
$1.80B
Reddito:
$97.36M
Utile/perdita netta:
$-172.42M
Rapporto P/E:
-10.56
EPS:
-2.2984
Flusso di cassa netto:
$-188.84M
1 W Prestazione:
-8.87%
1M Prestazione:
+12.42%
6M Prestazione:
+102.50%
1 anno Prestazione:
+190.19%
Xencor Inc Stock (XNCR) Company Profile
Nome
Xencor Inc
Settore
Industria
Telefono
626-305-5900
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
XNCR
Xencor Inc
|
24.26 | 1.85B | 97.36M | -172.42M | -188.84M | -2.2984 |
|
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-10-29 | Aggiornamento | Barclays | Underweight → Overweight |
| 2025-09-17 | Ripresa | Barclays | Underweight |
| 2025-09-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2024-12-12 | Iniziato | Wells Fargo | Overweight |
| 2024-12-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Reiterato | BTIG Research | Buy |
| 2024-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Iniziato | BofA Securities | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-10-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-01-21 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-02-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2020-02-25 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-01-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-08-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Iniziato | Mizuho | Buy |
| 2019-04-12 | Iniziato | Guggenheim | Buy |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-03-28 | Ripresa | Leerink Partners | Outperform |
| 2017-03-02 | Iniziato | Instinet | Neutral |
| 2017-03-02 | Reiterato | Wedbush | Outperform |
| 2016-10-04 | Iniziato | Piper Jaffray | Overweight |
| 2015-12-22 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-05 | Reiterato | MLV & Co | Buy |
| 2015-02-12 | Reiterato | Oppenheimer | Outperform |
| 2015-01-28 | Reiterato | MLV & Co | Buy |
| 2014-07-11 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Xencor Inc Borsa (XNCR) Ultime notizie
Xencor at 12th Annual Cantor Fitzgerald Global Healthcare Conference: late-stage shift - Investing.com Canada
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 260,752 Shares of Xencor, Inc. $XNCR - MarketBeat
The Manufacturers Life Insurance Company Buys Shares of 49,696 Xencor, Inc. $XNCR - MarketBeat
XNCR stock holds steady as Xencor eyes next trial milestones - ad-hoc-news.de
Seven Fleet Capital Management LP Has $5.93 Million Stake in Xencor, Inc. $XNCR - MarketBeat
Man Group plc Takes Position in Xencor, Inc. $XNCR - MarketBeat
Bank of New York Mellon Corp Makes New Investment in Xencor, Inc. $XNCR - MarketBeat
XNCR Maintained by JP Morgan -- Price Target Raised to $21.00 - GuruFocus
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock - MarketBeat
Technical Reactions to XNCR Trends in Macro Strategies - Stock Traders Daily
Xencor to Present at the 2026 Cantor Global Healthcare Conference - BioSpace
Xencor (XNCR) Maintained by Raymond James -- Price Target Raised to $46 - GuruFocus
Raymond James Adjusts Xencor Price Target to $46 From $40, Maintains Strong Buy Rating - marketscreener.com
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Xencor (NASDAQ:XNCR) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Hsbc Holdings PLC Buys Shares of 125,482 Xencor, Inc. $XNCR - MarketBeat
Legal & General Group Plc Acquires Shares of 1,091,177 Xencor, Inc. $XNCR - MarketBeat
Deutsche Bank AG Acquires New Shares in Xencor, Inc. $XNCR - marketbeat.com
Bank of America Corp DE Sells 263,315 Shares of Xencor, Inc. $XNCR - marketbeat.com
BlackRock Inc. Buys Shares of 13,651,261 Xencor, Inc. $XNCR - marketbeat.com
Xencor (NASDAQ:XNCR) Stock Price Down 9%What's Next? - MarketBeat
368,305 Shares in Xencor, Inc. $XNCR Bought by Seven Fleet Capital Management LP - MarketBeat
ADAR1 Capital Management LLC Invests $3.74 Million in Xencor, Inc. $XNCR - MarketBeat
Primecap Management Co. CA Invests $163.92 Million in Xencor, Inc. $XNCR - MarketBeat
Xencor (NASDAQ:XNCR) Reaches New 52-Week HighHere's Why - MarketBeat
Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the DayVolume Profile - vinanet.vn
103,736 Shares in Xencor, Inc. $XNCR Bought by DCF Advisers LLC - MarketBeat
Xencor stock hits 52-week high at 26.18 USD - Investing.com
Xencor stock hits 52-week high at 26.18 USD By Investing.com - Investing.com Canada
A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $20 to $44 - Moomoo
Xencor (NASDAQ:XNCR) Hits A Fresh High: What Comes Next? - Kalkine Media
Xencor (NASDAQ:XNCR) Sets New 52-Week HighShould You Buy? - MarketBeat
Xencor Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline? - simplywall.st
Johnson & Johnson Purchases New Shares in Xencor, Inc. $XNCR - MarketBeat
Industry Analysts Just Made A Huge Upgrade To Their Xencor, Inc. (NASDAQ:XNCR) Revenue Forecasts - simplywall.st
Analysts' Revenue Estimates For Xencor, Inc. (NASDAQ:XNCR) Are Surging Higher - Moomoo
(XNCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Biotech Stocks At 52-Week HighsBIVI +22%, XNCR, ANRO, HAE, ACAD - RTTNews
Xencor (NASDAQ:XNCR) Hits New 1-Year HighHere's What Happened - MarketBeat
XNCR Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.89% Share UptickFree Cash Flow Trends - vinanet.vn
Xencor stock hits 52-week high at 21.99 USD By Investing.com - Investing.com Canada
Xencor stock hits 52-week high at 21.99 USD - Investing.com
Cantor Fitzgerald Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $44 - Moomoo
Analysts Are Upgrading Xencor, Inc. (NASDAQ:XNCR) After Its Latest Results - webull.com
How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit - Yahoo Finance
BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $20 - Moomoo
Xencor (NASDAQ:XNCR) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Xencor Inc (XNCR) Stock News Today - TradingKey
Xencor, Inc. Stock 12‑Month Price Target Raised to $29, Implies 45% Upside - TradingView
Xencor, Inc. (XNCR) Stock Report: A Biotech Innovator With 40.83% Upside Potential - DirectorsTalk Interviews
Xencor Inc Azioni (XNCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):